A detailed history of Deutsche Bank Ag\ transactions in Pulmonx Corp stock. As of the latest transaction made, Deutsche Bank Ag\ holds 521,084 shares of LUNG stock, worth $3.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
521,084
Previous 524,660 0.68%
Holding current value
$3.3 Million
Previous $6.69 Million 27.79%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$8.71 - $14.65 $31,146 - $52,388
-3,576 Reduced 0.68%
521,084 $4.83 Million
Q4 2023

Feb 14, 2024

BUY
$7.89 - $13.14 $3.77 Million - $6.28 Million
477,792 Added 1019.44%
524,660 $6.69 Million
Q3 2023

Nov 09, 2023

SELL
$9.88 - $14.0 $4.85 Million - $6.87 Million
-490,932 Reduced 91.29%
46,868 $484,000
Q2 2023

Aug 14, 2023

SELL
$10.78 - $13.65 $57,629 - $72,972
-5,346 Reduced 0.98%
537,800 $7.05 Million
Q1 2023

May 15, 2023

BUY
$7.49 - $12.54 $51,418 - $86,087
6,865 Added 1.28%
543,146 $6.07 Million
Q4 2022

Feb 13, 2023

BUY
$4.92 - $17.35 $156,436 - $551,660
31,796 Added 6.3%
536,281 $4.52 Million
Q3 2022

Nov 14, 2022

SELL
$15.35 - $23.99 $4.54 Million - $7.09 Million
-295,736 Reduced 36.96%
504,485 $8.4 Million
Q2 2022

Aug 11, 2022

BUY
$14.0 - $27.95 $1.28 Million - $2.55 Million
91,313 Added 12.88%
800,221 $11.8 Million
Q1 2022

May 13, 2022

BUY
$21.13 - $35.65 $14.5 Million - $24.4 Million
684,887 Added 2851.2%
708,908 $17.6 Million
Q4 2021

Feb 11, 2022

SELL
$29.72 - $45.1 $343,919 - $521,897
-11,572 Reduced 32.51%
24,021 $771,000
Q3 2021

Nov 04, 2021

BUY
$35.98 - $44.48 $388,907 - $480,784
10,809 Added 43.61%
35,593 $1.28 Million
Q2 2021

Aug 11, 2021

BUY
$37.61 - $48.0 $39,866 - $50,880
1,060 Added 4.47%
24,784 $1.09 Million
Q1 2021

May 13, 2021

BUY
$44.0 - $67.54 $665,984 - $1.02 Million
15,136 Added 176.25%
23,724 $1.09 Million
Q4 2020

Feb 16, 2021

BUY
$39.31 - $69.02 $337,594 - $592,743
8,588 New
8,588 $593,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.